Pricing Log in Create free account
Friday 6 November 2026 Export ISRG’s income statement to Excel — free account

Intuitive Surgical, Inc.

ISRG Healthcare Medical Instruments & Supplies

Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024.

Revenue
+21.7%
EPS
−24.2%
Free cash flow
+51.0%

Quarter to September 2026, against a year earlier

465.68 16.42 −3.41%
Market cap
$162.4B
P/E
55.7×
Fwd P/E
49.8×
Dividend yield
—
F-score
7/9
Altman Z
50.09
Beneish M
−2.43
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Intuitive Surgical, Inc. (ISRG) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Intuitive Surgical, Inc. (ISRG) trades at a EV/EBITDA of 38.3×. Over the past ten years it has ranged from 18.6× (October 2015) to 74.8× (November 2024); the current reading is higher than 38% of that period. That is above the Medical Instruments & Supplies industry median of 14.9× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 54.2× (14.94%)
FY2024 63.7× 27.42%
FY2023 50.0× 8.91%
FY2022 45.9× (19.77%)
FY2021 57.2× (15.25%)
FY2020 67.5× 65.14%
FY2019 40.9× 5.98%
FY2018 38.6× 13.19%
FY2017 34.1× 62.68%
FY2016 20.9× (4.17%)

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 33.3× 4.57%
Jun 2026 31.9× (20.70%)
Mar 2026 40.2× (25.78%)
Dec 2025 54.2× 18.88%
43 more quarters

Against its own ten years

Low 18.6× High 74.8×
Ten-year median 41.7×
Current reading's percentile 38

EV/EBITDA against peers

Company EV/EBITDA
MDLN Medline Inc. compare 4.5×
SOLV Solventum Corporation compare 7.6×
BAX Baxter International Inc. compare 13.2×
ALC Alcon compare 14.8×
BDX Becton, Dickinson and Company compare 14.9×
RMD ResMed Inc. compare 15.7×
COO The Cooper Companies, Inc. compare 15.8×
WST West Pharmaceutical Services, Inc. compare 28.4×
ISRG Intuitive Surgical, Inc. 38.3×
Medical Instruments & Supplies industry median 14.9×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ISRG